ClinicalTrials.Veeva

Menu

A Wearable With Photoplethysmography and 6-lead Electrocardiography for Atrial Fibrillation Detection (DoubleCheckAF)

V

Vilnius University

Status

Completed

Conditions

Atrial Fibrillation

Treatments

Device: Monitoring with wearable (the tested device) and Holter ECG (eMotion Faros 90)

Study type

Observational

Funder types

Other

Identifiers

NCT04281927
S-MIP-17-81

Details and patient eligibility

About

A single center prospective case-control study to evaluate ability of a wearable to differentiate between atrial fibrillation (AF) and sinus rhythm (SR).

Enrollment

435 patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participants with current ECG-based diagnosis of atrial fibrillation, sinus rhythm or sinus rhythm with frequent (at least once in 2 minutes) premature atrial or ventricular contractions.
  • Age is between 18 - 99.

Exclusion criteria

  • Participants who refuse to sign an informed consent.
  • Participants with atrial fibrillation who are currently in a paced rhythm.

Trial design

435 participants in 3 patient groups

Atrial fibrillation
Description:
Patients with presumed atrial fibrillation will undergo monitoring with the device and Holter ECG.
Treatment:
Device: Monitoring with wearable (the tested device) and Holter ECG (eMotion Faros 90)
Sinus rhythm
Description:
Patients with presumed sinus rhythm will undergo monitoring with the device and Holter ECG.
Treatment:
Device: Monitoring with wearable (the tested device) and Holter ECG (eMotion Faros 90)
Sinus rhythm and frequent extrasystoles
Description:
Patients with presumed sinus rhythm and frequent extrasystoles will undergo monitoring with the device and Holter ECG.
Treatment:
Device: Monitoring with wearable (the tested device) and Holter ECG (eMotion Faros 90)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems